Profiel
Scott Moorefield served as the Senior Vice President of Business Development at Silverback Therapeutics, Inc. and as the Chief Business Officer at Boundless Bio, Inc. from 2019 to 2020.
He holds a doctorate degree from North Carolina State University, which he received in 2005, and an undergraduate degree from The University of North Carolina at Chapel Hill, which he received in 1996.
Eerdere bekende functies van Scott Moorefield
| Bedrijven | Functie | Einde |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2022 |
| BOUNDLESS BIO, INC. | Corporate Officer/Principal | 01-06-2020 |
Opleiding van Scott Moorefield
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| North Carolina State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
